Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04214769 Not yet recruiting - Clinical trials for Head and Neck Cancer Patients Treated With Radiotherapy

Effect of Radiation Therapy Among Head and Neck Cancer Patients on the Inner Ear Function

Start date: March 1, 2020
Phase:
Study type: Observational

Aims: 1. To evaluate the effects of radiation therapy on the inner ear, among patients treated with radiation therapy for head and neck cancers using a wide battery of tests (Audiometry and tympanometry, vHIT, VEMP, ENG) ; 2. To correlate the mean total radiation dose to the cochlea with the effects on audiological and vestibular function

NCT ID: NCT04214236 Not yet recruiting - Obesity Clinical Trials

CiNPT for Abdominoplasties in Post-bariatric Patients Study

CAPS
Start date: February 1, 2020
Phase: N/A
Study type: Interventional

The overarching goal of this research is to assess whether the post-operative use of closed-incision Negative Pressure Therapy (ciNPT) accelerates healing of surgical wounds, improves surgical outcomes, and reduces the rate of local complications in high-risk, obese, post-bariatric patients undergoing abdominal body-contouring procedures (abdominal panniculectomy or "abdominoplasty") compared to standard wound care. The investigators postulate that ciNPT can cost-effectively improve outcomes and standard of post-surgical care in this specific category of patients. This hypothesis will be tested through a prospective, interventional, case-control, randomized clinical trial.

NCT ID: NCT04213274 Not yet recruiting - Schnitzler Syndrome Clinical Trials

Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome

Start date: May 2023
Phase: Phase 2
Study type: Interventional

The primary goal of the study is to assess the efficacy and safety of RPH-104 in subjects with Schnitzler Syndrome using Schnitzler Disease Activity Score (SDAS), which includes the Physician's Global Assessment (PGA) and the local laboratory C-reactive protein (CRP) result

NCT ID: NCT04212624 Not yet recruiting - Clinical trials for Degenerative Myopia With Macular Hole

Clinical Research of Human Retinal Pigment Epithelial (HuRPE) Cell Injection on Atrophy of High Myopia Macular Area

Start date: December 2019
Phase: N/A
Study type: Interventional

To evaluate the safety and tolerability of human retinal pigment epithelial (HuRPE) cell injection subretinal transplantation for atrophy of high myopia macular area, and to explore the maximum tolerated dose (MTD).

NCT ID: NCT04210739 Not yet recruiting - Clinical trials for Chronic Non Bacterial Prostatitis

Chronic Non Bacterial Prostatitis: a Trial of TRUS Guided Injection of Betamethason

Start date: July 2020
Phase: Early Phase 1
Study type: Interventional

TRUS guided injection of long acting corticosteroids in chronic non bacterial prostatitis patients who failed to response to medical treamtment

NCT ID: NCT04208126 Not yet recruiting - Clinical trials for Acute Respiratory Distress Syndrome

Early Versus Late Initiation of ECMO (Extracorporal Membrane Oxygenation) Trial (ELIEO-Trial)

ELIEO
Start date: April 2022
Phase: N/A
Study type: Interventional

This trial is a prospective randomized multicenter trial that assigns patients to either a treatment for Acute Respiratory Distress Syndrome (ARDS) with an Extracorporal Membrane Oxygenation (ECMO) immediately after admission to the intensive care unit or conservative treatment. The later can undergo ECMO following failure of conservative therapy as a rescue therapy. Patients will be included within 96h of the onset of symptoms of ARDS and will be randomized according to standard procedure. Follow-up will be performed until hospital discharge.

NCT ID: NCT04207814 Not yet recruiting - Clinical trials for Repeated Spontaneous Miscarriages

Determinants of Repeated Spontaneous Miscarriages and Unexplained Fetal Deaths

DEFI-2
Start date: January 2020
Phase: N/A
Study type: Interventional

The DEFI-1 study recruited 625 women witnesses and 299 of their spouses. With regard to case couples, 271 cases were recruited from the spontaneous repeated miscarriages (SRM) subgroup (≥3 spontaneous miscarriage (SM) from trimester 1 of pregnancy) and 93 from the unexplained fetal death in utero (FDIU) subgroup from trimesters 2 and 3 of pregnancy. The main objective of the DEFI 2 study is to increase the number of case-pairs in these 2 particular subgroups to replicate the results of the genetic determinants highlighted from cases and controls with extreme phenotypes and obtain a sufficient number of women with FDIUs to identify specific determinants.

NCT ID: NCT04205578 Not yet recruiting - Ischemic Stroke Clinical Trials

NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events

NICE-MMD
Start date: January 2020
Phase: Phase 3
Study type: Interventional

An extracranial-to-intracranial (EC-IC) revascularization is the most widely used treatment to improve cerebral perfusion in patients with moyamoya disease (MMD), and it has been shown to reduce the risk of subsequent stroke and neurological deficit. However, perioperative changes in cerebral hemodynamics can induce fluctuations in cerebral perfusion that may lead to transient or irreversible neurological deficits. Our preliminary single-center study suggests that postoperative intravenous administration of dl-3-n-butylphthalide (NBP) may alleviate perioperative neurological deficits and improve the neurological outcomes after EC-IC revascularization for MMD. This is a multicenter, randomized, double-blind, single-controlled, add-on to standard of care study of NBP in patients with MMD of high risk for ischemic cerebrovascular events after EC-IC revascularization surgery.

NCT ID: NCT04204031 Not yet recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Objective Evaluation of the Number of Use Hour of Oxygen Therapy in Patients Receiving Supplemental Oxygen

MONOX
Start date: January 2, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to measure the actual use time in patients receiving supplemental oxygen using a new easy-to-use electronic remote monitoring device (TeleOx™)

NCT ID: NCT04203992 Not yet recruiting - Clinical trials for Performance Enhancing Product Use

Videogame for the Prevention of Doping and Supplement Abuse in Teenage Athletes

Start date: November 2020
Phase: N/A
Study type: Interventional

The purpose of this research is to test the effectiveness of an interactive doping education videogame among student athletes. Specifically, the game will teach athletes aged 13-16 years about the risks of doping and will foster the values, motivation, and behavioural skills needed to avoid temptation and pressure to dope. The investigators hypothesize that student athletes who play the intervention game will have lower use of banned substances and sport supplements, greater intentions to stay clean, and will also show improvements in the cognitive and motivational antecedents to doping when compared to a control condition.